IMPACT OF POLICY MEASURES AND GENERIC COMPETITION ON PHARMACEUTICAL EXPENDITURE IN BELGIUM

被引：0
|
作者：
Dupont, A. G. [1 ]
机构：
[1] Vrije Univ Brussel, UZ Brussel, Klin Farmacol Farmacotherapie, Brussels, Belgium
来源：
ACTA CLINICA BELGICA | 2012年 / 67卷 / 03期
关键词：
SUBSTITUTION; REIMBURSEMENT; PATTERNS;
D O I：
10.2143/ACB.67.3.2062648
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 153
页数：3
相关论文
共 50 条
  • [31] DOES PHARMACEUTICAL PRICE REGULATION AFFECT THE ADOPTION OF GENERIC COMPETITION IN THE OECD?
    Varol, N.
    Costa-i-Font, J.
    McGuire, A. J.
    VALUE IN HEALTH, 2011, 14 (07) : A336 - A336
  • [32] Trends in ACEi and ARB expenditure: Compelling case for competition in generic drug markets
    Batty, Jonathan A.
    Hall, Marlous
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 370 : 419 - 420
  • [33] Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future
    Simoens, Steven
    De Bruyn, Kristien
    Miranda, Jamilette
    Bennie, Marion
    Malmstrom, Rickard E.
    Godman, Brian
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2013, 4 (03) : 173 - 181
  • [34] Time series analysis of pharmaceutical public expenditure: Evaluation of supply measures
    Luque, Magem D.
    Gilabert i Perramon, A.
    VALUE IN HEALTH, 2006, 9 (06) : A214 - A215
  • [35] Analysis of several containment measures of pharmaceutical expenditure in an Ambulatory Surgery Centre
    Esteban, J. L.
    Leon, A.
    Porras, I.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2013, 60 (09): : 498 - 503
  • [36] THE IMPACT OF POLICY MEASURES TO INCREASE THE UPTAKE OF BIOSIMILAR MEDICINES IN BELGIUM: A NATIONWIDE INTERRUPTED TIME SERIES ANALYSIS
    Vandenplas, Y.
    Simoens, S.
    Van Wilder, P.
    Vulto, A.
    Huys, I
    VALUE IN HEALTH, 2022, 25 (12) : S253 - S253
  • [37] IMPACT OF GENERICS POLICY ON THE GENERIC PENETRATION
    Ammar, H.
    Remuzat, C.
    Toumi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A297 - A297
  • [38] GENERIC COMPETITION AND PHARMACEUTICAL INNOVATION - THE DRUG PRICE-COMPETITION AND PATENT TERM RESTORATION ACT OF 1984
    WHEATON, JJ
    CATHOLIC UNIVERSITY LAW REVIEW, 1986, 35 (02): : 433 - 487
  • [39] IMPACT OF THE "PUENTE PROJECT" ON THE PUBLIC DISEASE EXPENDITURE OF A PATIENT WITH SCHIZOPHRENIA IN BELGIUM
    Van Loon, H.
    Vandenbroele, H.
    De Bruyne, S.
    Glorieux, M.
    Wybo, A.
    Gillain, B.
    Dubois, V.
    Peuskens, J.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [40] PHARMACEUTICAL EXPENDITURE FORECAST MODEL TO SUPPORT HEALTH POLICY DECISION MAKING
    Remuzat, C.
    Toumi, M.
    Vataire, A. L.
    Cetinsoy, L.
    Aballea, S.
    VALUE IN HEALTH, 2013, 16 (03) : A255 - A255
12345